Dr. Gawande, if confirmed by the Senate, would serve at a bureau comprising nine offices that support USAID’s global health efforts.
“I’m honored to be nominated to lead global health development at @USAID, including for COVID,” Dr. Gawande tweeted. “With more COVID deaths worldwide in the first half of 2021 than in all of 2020, I’m grateful for the chance to help end this crisis and to re-strengthen public health systems worldwide.”
Dr. Gawande, a surgeon, writer and public health leader, is the Cyndy and John Fish Distinguished Professor of Surgery at Boston-based Brigham and Women’s Hospital and a professor at Harvard Medical School and the Harvard T.H. Chan School of Public Health.
He also is founder and chair of Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health, and Lifebox, a global nonprofit focused on improving surgery and anesthesia safety worldwide.
Additionally, Dr. Gawande co-founded CIC Health, which operates COVID-19 testing and vaccination in the U.S.
He is former CEO of Haven, the healthcare partnership formed by Amazon, JPMorgan Chase and Berkshire Hathway, which has disbanded.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.